Centrient Pharmaceuticals

    OverviewSuggest Edit

    Centrient Pharmaceuticals is a company that manufactures enzymatic antibiotics, statins, and antifungals. It produces and sells intermediates and active pharmaceutical ingredients (APIs), as well as tablets, capsules, and other finished dosage forms (FDFs).
    TypePrivate
    Founded1869
    HQRotterdam, NL
    Websitecentrient.com
    Employee Ratings3.9

    Latest Updates

    Employees (est.) (Jan 2022)644
    Cybersecurity ratingCMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Centrient Pharmaceuticals

    Frans Vlaar

    Frans Vlaar

    Chief Commercial Officer API
    Rex Clements

    Rex Clements

    Chief Executive Officer
    Osvaldo Garcia

    Osvaldo Garcia

    Assistant Group Controller and Finance for Growth Project Director
    Alba Tiley

    Alba Tiley

    Global Director Sustainable Antibiotics Program
    Ronald Merckx

    Ronald Merckx

    Chief Financial Officer
    Fangbin Lu

    Fangbin Lu

    Global Vice President and China Lead
    Show more

    Centrient Pharmaceuticals Office Locations

    Centrient Pharmaceuticals has offices in Rotterdam, Delft, Parsippany-Troy Hills, Zibo Shi and in 6 other locations
    Rotterdam, NL (HQ)
    Weena 798
    Delft, NL
    Alexander Fleminglaan 1, 5th
    Zibo Shi, CN
    Bei Ling Lu, Zhangdian Qu
    Gurugram, IN
    DLF Cyber City, DLF Phase 2, Sector 24
    Rail, IN
    Bhai Mohan Singh Nagar Toansa
    Thane, IN
    1, Hiranandani Estate, Thane West
    Show all (11)

    Centrient Pharmaceuticals Financials and Metrics

    Summary Metrics

    Founding Date

    1869

    Centrient Pharmaceuticals Cybersecurity Score

    Cybersecurity ratingPremium dataset

    C

    70/100

    SecurityScorecard logo

    Centrient Pharmaceuticals Online and Social Media Presence

    Embed Graph

    Centrient Pharmaceuticals News and Updates

    Centrient Pharmaceuticals boosting statins API manufacturing capacity

    Rotterdam, The Netherlands, June 21, 2021 (GLOBE NEWSWIRE) -- Summary:

    Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms

    Rotterdam, the Netherlands, February 15th, 2021, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the signing of an agreement for the acquisit…

    Centrient Pharmaceuticals Frequently Asked Questions

    • When was Centrient Pharmaceuticals founded?

      Centrient Pharmaceuticals was founded in 1869.

    • Who are Centrient Pharmaceuticals key executives?

      Centrient Pharmaceuticals's key executives are Frans Vlaar, Rex Clements and Osvaldo Garcia.

    • How many employees does Centrient Pharmaceuticals have?

      Centrient Pharmaceuticals has 644 employees.

    • Who are Centrient Pharmaceuticals competitors?

      Competitors of Centrient Pharmaceuticals include Siegfried Holding, BNC KOREA and Medley Pharmaceuticals.

    • Where is Centrient Pharmaceuticals headquarters?

      Centrient Pharmaceuticals headquarters is located at Weena 798, Rotterdam.

    • Where are Centrient Pharmaceuticals offices?

      Centrient Pharmaceuticals has offices in Rotterdam, Delft, Parsippany-Troy Hills, Zibo Shi and in 6 other locations.

    • How many offices does Centrient Pharmaceuticals have?

      Centrient Pharmaceuticals has 11 offices.